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Collecting duct epithelium  
and injury: Not all cells are  
created equal
TD Hewitson1,2
Studies by Butt et al. in the developing fetus provide new and timely 
insights into the regulation of repair and fibrosis in the injured kidney. 
Using a clinically relevant model, they have examined the response 
of the medullary collecting duct to ureteral obstruction, with some 
unexpected findings.
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The kidney’s response to injury is analo-
gous to the generalized models of wound 
healing, a process designed to repair 
injury and restore tissue function. How-
ever, whereas acute wounds go through a 
linear series of events, chronic non-heal-
ing wounds do not. Some areas of chronic 
wounds are in diﬀerent phases at the same 
time, and progression to the next phase 
does not occur in the same coordinated 
manner. What makes this process even 
worse in renal disease is that the kidney 
has a very limited capacity for repair after 
prolonged injury. After acute injury, as 
long as a scaﬀold of basement membrane 
exists, individual cells, especially tubular 
epithelia, can regenerate by proliferation. 
Likewise, in some cases at least, these can 
be supplemented by circulating stem cells.1 
Conversely, more advanced injury is associ-
ated with destruction of tubular basement 
membranes and tubular atrophy, both of 
which appear irreversible.2 The end result 
of this process is the failure of the wound 
to heal and accumulation of excess matrix, 
so-called scarring. Although we recognize 
that the extent of tubulointerstitial ﬁbrosis 
in particular correlates well with decline 
in renal function, we often forget that it is 
not the ﬁbrosis itself that is important, but 
rather the destructive eﬀects of ﬁbrosis on 
tubules and capillaries2 (Figure 1).
These processes involve hematogenous 
cells, connective tissue cells such as 
ﬁbroblasts, and associated resident mac-
rophages and lymphocytes. Although 
monoclonal antibodies have long been 
used to phenotype the inﬁltrating hema-
togenous cells in various forms of inﬂam-
mation, the absence of speciﬁc markers 
for ﬁbroblasts has meant that their enu-
meration has been diﬃcult. Other than 
the myofibroblast, there is no formal 
nomenclature to describe these cells.
Despite the inherent problems, we have 
been able to determine that the ﬁbroblast 
is central to both wound healing and the 
pathogenesis of organ ﬁbrosis. Fibroblasts 
are present in many tissues in the body, 
normally in a relatively quiescent state, 
and are mainly responsible for the produc-
tion and turnover of extracellular matrix 
molecules. For more than 30 years we have 
known that during tissue repair, ﬁbroblasts 
change phenotype to a contractile, hyper-
proliferative, and upregulated producer 
of extracellular matrix. Recognized from 
its de novo expression of α-smooth mus-
cle actin, the so-called myoﬁbroblast has 
been described in all forms of progressive 
renal disease. Not surprisingly, consider-
able interest has therefore centered on the 
regulation of this cell and in particular 
the factors that control its diﬀerentiation, 
kinetics, and matrix production. These 
studies have led us to recognize that the 
ﬁbroblasts present in various connective 
tissues represent a heterogeneous popu-
lation of cells. Their activity and diﬀeren-
tiation are dependent on a combination of 
growth factors and other soluble media-
tors, extracellular matrix components, and 
mechanical stress.3
An underlying basis for this hetero-
geneity may lie in the diverse origins of 
these cells.
Electron microscopy studies have 
always shown that there is a resident 
population of renal ﬁbroblast-like cells. 
Until relatively recently, it was assumed 
that ﬁbroblasts were derived solely from 
their local proliferation and migration 
from adjacent tissues, in particular the 
perivascular region.4
It was therefore signiﬁcant when Bucala 
et al.5 isolated a population of so-called 
fibrocytes in healing skin wounds that 
expressed both the hematogenous cell 
marker CD34 and procollagen I. In sex-
mismatched bone marrow transplants, the 
authors demonstrated mismatched DNA 
in these cells to conﬁrm that they were of 
donor origin. Likewise, there are now also 
reports that bone marrow-derived ﬁbro-
cytes traﬃc to areas of renal ﬁbrosis.6
Fibroblasts may also be derived from 
epithelial–mesenchymal transition (EMT). 
The concept of EMT comes from studies 
of embryonic development, in which EMT 
and the reverse process, mesenchymal–epi-
thelial transition, are central mechanisms 
facilitating the derivation of a multitude of 
functionally specialized cells in the kid-
ney.7 In the adult, such transitions were 
largely unknown. Of late, however, it has 
been noted that embryonic EMT can be 
recapitulated during certain adult disease 
states such as cancer and ﬁbrosis, whereby 
dramatic morphological and functional 
changes take place to allow cells to develop 
a migratory and invasive capacity.
During EMT, epithelial cells lose polarity 
and cell–cell contacts and undergo dra-
matic cytoskeletal remodeling. Concur-
rent with the loss of epithelial-cell adhesion 
and cytokeratins, cells undergoing EMT 
acquire mesenchymal-cell expression pro-
ﬁles. Migration of these cells into the sur-
rounding interstitium is facilitated by the 
degradation of basement membranes.
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Unilateral ureteric obstruction has 
become the most recognized model of 
renal tubulointerstitial ﬁbrogenesis, its 
popularity driven by the absence of con-
founding glomerular pathology and its 
easy adaptation to genetically modiﬁed 
mice. Almost all studies have focused on 
the cortex, despite the obvious involve-
ment of the renal pelvis.
Elegant experiments in a murine model 
of unilateral ureteric obstruction have 
attempted to address the relative impor-
tance of the various potential sources of 
ﬁbroblasts. Using bone marrow chimeras 
and transgenic reporter mice, Iwano et 
al.8 were able to estimate that circulat-
ing precursors and EMT contributed 
15% and 36% of the ﬁbroblast burden, 
respectively. For technical reasons, only 
proximal tubule epithelium was trans-
fected in this study, meaning that the 
role of EMT in other nephron segments 
remains poorly deﬁned.
The study by Butt et al.9 (this issue) 
therefore provides interesting insights 
into both EMT and the pathophysiol-
ogy of fetal ureteric obstruction in gen-
eral. Using ultrasound for guidance, the 
authors have been able to obstruct a sin-
gle ureter in fetal monkeys during the 
early second trimester. This is an impor-
tant model because there are substantial 
diﬀerences between the wound healing 
process in the fetus and that in the adult. 
Ureteric obstruction in the fetus is accom-
panied not only by interstitial ﬁbrosis, as 
in the adult, but also by disrupted neph-
rogenesis resulting in decreased glomeru-
lar endowment. Given the considerable 
gestational diﬀerences between species, 
the authors’ ﬁndings in a nonhuman pri-
mate are highly relevant to the human 
condition.
Fetal medullary collecting ducts con-
tained two morphologically and biochem-
ically distinct cell populations: principal 
and intercalated cells, recognized by their 
staining for water channel AQP2 and car-
bonic anhydrase II (CAII), respectively. 
Unlike in the adult kidney, Butt and col-
leagues9 have been able to identify a resi-
dent population of fetal cells coexpressing 
α-smooth muscle actin and CAII, which 
migrate in response to injury. Conversely, 
the population of fetal principal cells, 
some 80% of the collecting ducts, prolif-
erate locally in response to injury, do not 
acquire ﬁbroblastic features, and presum-
ably did not migrate to the interstitium. 
Their response seems to be more consist-
ent with an attempt to repair gaps in the 
injured epithelial layer.
In the past, studies of EMT have 
focused on the proximal tubule, which 
is derived from the embryonic mesen-
chyme. Importantly, the study by Butt 
et al.9 leads us to consider the process in 
cells with other derivations.
The role of EMT is not without con-
troversy. Even though transitional cells 
are well described, there are few prac-
tical demonstrations of their migrat-
ing through the basement membrane. 
Ultrastructural demonstration of this is 
diﬃcult given that so few cells are aﬀected 
at any one time. The use of confocal 
microscopy by Butt et al.9 has to some 
extent overcome this by combining his-
tochemistry and resolution.
The significance of these findings is 
far from certain, but they do once again 
highlight the plasticity of cell pheno-
type and the possibility of diﬀerent pre-
programmed responses to injury. Like 
so much in medicine, this work raises 
many more questions. Further studies 
may help us determine whether CAII/α-
smooth muscle actin-positive cells are a 
population of progenitor cells that can 
diﬀerentiate into either principal cells 
or myoﬁbroblasts. Likewise, depletion 
of these cells may have implications for 
subsequent injury.
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Figure 1 | Summary of kidney response to acute and ongoing injury.
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